{"title":"Primary Breast Lymphoma: A Rare but Important Differential Diagnosis in Patients with Breast Malignancy.","authors":"Irappa Madabhavi, Malay Sarkar, Raghavendra Sagar, Swaroop Revannasiddaiah, Vineet Kumar","doi":"10.1055/s-0044-1789604","DOIUrl":null,"url":null,"abstract":"<p><p>This report is based upon the case of a young lady who presented with a history of a breast lump, which despite clinically resembling a carcinoma, was subsequently diagnosed to be a primary breast lymphoma (PBL). Though rare in incidence, PBL may masquerade as breast carcinoma. PBL accounts for about 1.7-2.2% of all extranodal non-Hodgkin's lymphoma, and is accountable for up to 0.5% of all breast malignancies. Given that the treatments of breast carcinoma and PBL are markedly different, it is very essential that core-biopsy be preferred in every patient being evaluated for carcinoma of the breast. The diagnosis of diffuse large B cell lymphoma (DLBCL) was confirmed by immunohistochemistry, and the patient has been treated with six-cycles of chemotherapy followed by involved field-radiotherapy to the right breast. After a year's follow-up, the patient remains free of disease.</p>","PeriodicalId":22053,"journal":{"name":"South Asian Journal of Cancer","volume":"14 3","pages":"517-519"},"PeriodicalIF":0.7000,"publicationDate":"2024-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12727010/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"South Asian Journal of Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0044-1789604","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
This report is based upon the case of a young lady who presented with a history of a breast lump, which despite clinically resembling a carcinoma, was subsequently diagnosed to be a primary breast lymphoma (PBL). Though rare in incidence, PBL may masquerade as breast carcinoma. PBL accounts for about 1.7-2.2% of all extranodal non-Hodgkin's lymphoma, and is accountable for up to 0.5% of all breast malignancies. Given that the treatments of breast carcinoma and PBL are markedly different, it is very essential that core-biopsy be preferred in every patient being evaluated for carcinoma of the breast. The diagnosis of diffuse large B cell lymphoma (DLBCL) was confirmed by immunohistochemistry, and the patient has been treated with six-cycles of chemotherapy followed by involved field-radiotherapy to the right breast. After a year's follow-up, the patient remains free of disease.